- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05106452
Effect of ANI on Intraoperative Opioid Consumption
November 4, 2021 updated by: Çağdaş Baytar, Zonguldak Bulent Ecevit University
Intraoperative Analgesia Management in Gynecological Surgery With Erector Spinae Block
The aim of the study is to compare the analgesic nociception index (ANI), which is used to determine the dose of analgesic agent needed in the intraoperative period, with the conventional method in patients with erector spinae block who underwent gynecological surgery under general anesthesia.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
35
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: çağdaş baytar, MD
- Phone Number: +905542255960
- Email: cagdasbaytar31@gmail.com
Study Locations
-
-
Kozlu
-
Zonguldak, Kozlu, Turkey, 67600
- Recruiting
- Zonguldak Bülent Ecevit University Medicine Faculty
-
Contact:
- Murat Can, prof.dr
- Phone Number: +90 372 261 20 15
- Email: beuntipfakultesi@beun.edu.tr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
female patients gynecological surgery under general anesthesia
Description
Inclusion Criteria:
- ASA I-II-III risk group
- Patients who underwent gynecological surgery under general anesthesia, who underwent erector spina block, and whose pain was followed by analgesia nociception index or conventional methods for intraoperative pain monitoring
- Patients whose informed consent was read and consent was obtained from them and their guardians
Exclusion Criteria:
- cardiac rhythm disorder
- central-autonomic nervous system disease
- neuropsychiatric disease
- receiving opioid therapy
- Use of drugs that will affect cardiac autonomic regulation
- Known allergy to the drugs to be applied
- Contraindicated for ESP block
- Patients who do not agree to participate in the study will not be included in the study.
- Patients who were administered drugs to stabilize the patient's hemodynamics during the operation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Group ANI
|
|
Group Control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative opioid consumption
Time Frame: during the surgery
|
Effect of ANI monitoring on intraoperative opioid consumption
|
during the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
emergence time
Time Frame: at the end of the surgery
|
time between last suture and extubation
|
at the end of the surgery
|
|
VAS pain scores
Time Frame: during her stay in the recovery unit
|
pain scores in the recovery unit
|
during her stay in the recovery unit
|
|
duration of stay in recovery room
Time Frame: at the end of the surgery
|
time between entering and exiting the recovery unit
|
at the end of the surgery
|
|
nausea and vomiting i
Time Frame: during her stay in the recovery unit
|
incidence of nausea and vomiting in recovery room
|
during her stay in the recovery unit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2021
Primary Completion (Anticipated)
February 28, 2023
Study Completion (Anticipated)
May 1, 2023
Study Registration Dates
First Submitted
October 22, 2021
First Submitted That Met QC Criteria
October 22, 2021
First Posted (Actual)
November 3, 2021
Study Record Updates
Last Update Posted (Actual)
November 11, 2021
Last Update Submitted That Met QC Criteria
November 4, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021/18-4
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.